Phase II Theophylline Radioimmunoassay

FDA 510(k) K833789 · Medical & Scientific Designs, Inc.

Substantially Equivalent

510(k) numberK833789

Submission

Device name
Phase II Theophylline Radioimmunoassay
Applicant
Medical & Scientific Designs, Inc.
Mchenry, IL, US
Received
October 31, 1983
Decision date
January 24, 1984
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
LCA – Radioimmunoassay, Theophylline
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3880
Specialty
Clinical Toxicology

Other 510(k)s with product code LCA

510(k)DeviceApplicantDecision
K880291Theophylline Test Kit Ref. #A874799LCA · Traditional Photec Diagnostics, Inc.03/24/1988SE
K821862Quanticoat 125 I-Theophylline Radioimm.LCA · Traditional Kallestad Laboratories, Inc.07/06/1982SE
K821347Bio-Mag Theophylline (125I) Radioimmun.LCA · Traditional Bioclinical Corp.05/28/1982SE
K792062Theophylline RiassayLCA · Traditional Ria Diagnostics02/25/1980SE

More from Ria Diagnostics

510(k)DeviceDecision
K862960Phase II Ferritin Radioimmunoassay KitDBF · Traditional 08/27/1986SE
K853224Phase II B-12/FOLATE KitCDD · Traditional 10/03/1985SE
K840901Phase II Free T4 KitCEC · Traditional 04/25/1984SE
K840328Phase II HCG KitJHI · Traditional 04/19/1984SE
K834219Phase II Cortisol KitCGR · Traditional 02/04/1984SE
K832499Phase II TSH KitJLW · Traditional 09/12/1983SE
K832210Gamma Photon Gamma CounterJJJ · Traditional 08/24/1983SE
K832209Kineti Count 24 Gamma CounterJJJ · Traditional 08/24/1983SE
K831064Phase II T3 Radioimmunoassay KitCDP · Traditional 05/09/1983SE
K830900Uptake T3 Radioimmunoassay KitKHQ · Traditional 04/18/1983SE

Questions and answers

When was Phase II Theophylline Radioimmunoassay cleared by the FDA?

Phase II Theophylline Radioimmunoassay (K833789) received a 510(k) decision of Substantially Equivalent on January 24, 1984, 85 days after the submission was received.

What is the product code of K833789?

The FDA product code is LCA – Radioimmunoassay, Theophylline, a Class II (moderate risk) device regulated under 21 CFR 862.3880.